Best Practice & Research Clinical Rheumatology
Volume 22, Issue 5 , Pages 773-792 , October 2008

Adult-onset Still disease

  • Bruno Fautrel, MD, PhD (Professor)

      Affiliations

    • Corresponding Author InformationTel.: +33 1 421 77620; Fax: +33 1 421 77955.

References 

  1. Bywaters EG. Still's disease in the adult. Annals of the Rheumatic Diseases. 1971;30:121–133
  2. Ohta A, Yamaguchi M, Kaneoka H, et al. Adult Still's disease: review of 228 cases from the literature. Journal of Rheumatology. 1987;14:1139–1146
  3. Ohta A, Yamaguchi M, Tsunematsu T, et al. Adult Still's disease: a multicenter survey of Japanese patients. Journal of Rheumatology. 1990;17:1058–1063
  4. Kahn MF. Adult Still's disease. Still many issues unresolved. Journal of Rheumatology. 1996;23:2015–2016
  5. Masson C, Le Loet X, Liote F, et al. Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France. Revue du Rhumatisme (English ed.). 1995;62:748–757
  6. Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991;70:118–136
  7. Fautrel B, Le Moel G, Saint-Marcoux B, et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. Journal of Rheumatology. 2001;28:322–329
  8. Wouters JM, van de Putte LB. Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Quarterly Journal of Medicine. 1986;61:1055–1065
  9. Chen DY, Lan JL, Hsieh TY, et al. Clinical manifestations, disease course, and complications of adult-onset Still's disease in Taiwan. Journal of the Formosan Medical Association. 2004;103:844–852
  10. Pay S, Turkcapar N, Kalyoncu M, et al. A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis. Clinical Rheumatology. 2006;25:639–644
  11. Magadur-Joly G, Billaud E, Barrier JH, et al. Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. Annals of the Rheumatic Diseases. 1995;54:587–590
  12. Wakai K, Ohta A, Tamakoshi A, et al. Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan. Journal of Epidemiology. 1997;7:221–225
  13. van de Putte LB, Wouters JM. Adult-onset Still's disease. Baillière's Clinical Rheumatology. 1991;5:263–275
  14. Arlet JB, Le Thi Huong DB, Pouchot J, et al. Physiopathologie de la maladie de Still de l'adulte. La Revue de Médecine Interne. 2005;26:549–556
  15. Efthimiou P, Kontzias A, Ward CM, et al. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?. Nature Clinical Practice. Rheumatology. 2007;3:328–335
  16. Ohta A, Matsumoto Y, Ohta T, et al. Still's disease associated with necrotizing lymphadenitis (Kikuchi's disease): report of 3 cases. Journal of Rheumatology. 1988;15:981–983
  17. Quaini F, Manganelli P, Pileri S, et al. Immunohistological characterization of lymph nodes in two cases of adult onset Still's disease. Journal of Rheumatology. 1991;18:1418–1423
  18. Koeller M, Kiener H, Simonitsch I, et al. Destructive lymphadenopathy and T-lymphocyte activation in adult-onset Still's disease. British Journal of Rheumatology. 1995;34:984–988
  19. Reichert LJ, Keuning JJ, van Beek M, et al. Lymph node histology simulating T-cell lymphoma in adult-onset Still's disease. Annals of Hematology. 1992;65:53–54
  20. Jeon YK, Paik JH, Park SS, et al. Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy. Journal of Clinical Pathology. 2004;57:1052–1056
  21. Fujii T, Akizuki M, Kameda H, et al. Methotrexate treatment in patients with adult onset Still's disease–retrospective study of 13 Japanese cases. Annals of the Rheumatic Diseases. 1997;56:144–148
  22. Hoshino T, Ohta A, Yang D, et al. Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease. Journal of Rheumatology. 1998;25:396–398
  23. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. Journal of Allergy and Clinical Immunology. 1999;103:11–24
  24. Kawashima M, Yamamura M, Taniai M, et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis and Rheumatism. 2001;44:550–560
  25. Kawaguchi Y, Terajima H, Harigai M, et al. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease. Arthritis and Rheumatism. 2001;44:1716–1717
  26. Choi JH, Suh CH, Lee YM, et al. Serum cytokine profiles in patients with adult onset Still's disease. Journal of Rheumatology. 2003;30:2422–2427
  27. Chen DY, Lan JL, Lin FJ, et al. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. Journal of Rheumatology. 2004;31:2189–2198
  28. Ogata A, Kitano M, Yamanaka J, et al. Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. Journal of Rheumatology. 2003;30:1093–1096
  29. Chen DY, Lan JL, Lin FJ, et al. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease. Arthritis and Rheumatism. 2005;53:320–327
  30. Sanmarti R, Canete JD, Salvador G. Palindromic rheumatism and other relapsing arthritis. Best Practice & Research. Clinical Rheumatology. 2004;18:647–661
  31. Grateau G, Jeru I, Rouaghe S, et al. Amyloidosis and auto-inflammatory syndromes. Current Drug Targets. Inflammation and Allergy. 2005;4:57–65
  32. Crispin JC, Martinez-Banos D, Alcocer-Varela J. Adult-onset still disease as the cause of fever of unknown origin. Medicine (Baltimore). 2005;84:331–337
  33. Kontzias A, Efthimiou P. Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs. 2008;68:319–337
  34. Fujii T, Nojima T, Yasuoka H, et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology (Oxford). 2001;40:1398–1404
  35. Wouters JM, Reekers P, van de Putte LB. Adult-onset Still's disease. Disease course and HLA associations. Arthritis and Rheumatism. 1986;29:415–418
  36. Pouchot J. How can we improve the management of adult-onset Still's disease?. Joint Bone Spine. 2007;74:117–119
  37. Reginato AJ, Schumacher HR, Baker DG, et al. Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Seminars in Arthritis and Rheumatism. 1987;17:39–57
  38. Pouchot J and Fautrel B. Maladie de Still de l'adulte. In: Piette JC, Meyer O and Sibilia J, eds. Maladies et syndromes systémiques. 5th edn., in press. Paris: Flammarion–Médecine Sciences, 2008.
  39. Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Annals of the Rheumatic Diseases. 2006;65:564–572
  40. Medsger TA, Christy WC. Carpal arthritis with ankylosis in late onset Still's disease. Arthritis and Rheumatism. 1976;19:232–242
  41. Cohen C, Geller B, Whang EJ, et al. Adult Still's disease presenting as serum sickness. International Journal of Dermatology. 1997;36:928–931
  42. Boki KA, Tsirantonaki MJ, Markakis K, et al. Thrombotic thrombocytopenic purpura in adult Still's disease. Journal of Rheumatology. 1996;23:385–387
  43. Bujak JS, Aptekar RG, Decker JL, et al. Juvenile rheumatoid arthritis presenting in the adult as fever of unknown origin. Medicine (Baltimore). 1973;52:431–444
  44. Nguyen KH, Weisman MH. Severe sore throat as a presenting symptom of adult onset Still's disease: a case series and review of the literature. Journal of Rheumatology. 1997;24:592–597
  45. Lyberatos C. Two more cases of Still's disease and Kikuchi's. Journal of Rheumatology. 1990;17:568–569
  46. Samuels AJ, Berney SN, Tourtellotte CD, et al. Coexistence of adult onset Still's disease and polymyositis with rhabdomyolysis successfully treated with methotrexate and corticosteroids. Journal of Rheumatology. 1989;16:685–687
  47. Moreno-Alvarez MJ, Citera G, Maldonado-Cocco JA, et al. Adult Still's disease and inflammatory myositis. Clinical and Experimental Rheumatology. 1993;11:659–661
  48. Paccalin M, Chapon C, Roblot P, et al. Manifestation pulmonaire grave de la maladie de Still de l'adulte. La Revue de Médecine Interne. 1997;18:575–577
  49. Fautrel B. Maladie de Still de l'adulte. In:  Dechy H,  Wechsler B,  Hausfater P,  Rancurel G,  Piette JC editor. Atteintes neurologiques au cours des maladies systémiques. Paris: Flammarion Médecine-Sciences; 2003;p. 175–180
  50. Wendling D, Humbert P, Hory B, et al. Le rein de la maladie de Still de l'adulte. Revue du Rhumatisme et des Maladies Ostéo-articulaires. 1989;56:325–327
  51. Harrington TM, Moran JJ, Davis DE. Amyloidosis in adult onset Still's disease. Journal of Rheumatology. 1981;8:833–836
  52. Elkon KB, Hughes GR, Bywaters EG, et al. Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease. Arthritis and Rheumatism. 1982;25:647–654
  53. Cabane J, Michon A, Ziza JM, et al. Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years. Annals of the Rheumatic Diseases. 1990;49:283–285
  54. Rivera F, Gil CM, Gil MT, et al. Vascular renal AA amyloidosis in adult Still's disease. Nephrology, Dialysis, Transplantation. 1997;12:1714–1716
  55. Kumakura S, Ishikura H, Munemasa S, et al. Adult onset Still's disease associated hemophagocytosis. Journal of Rheumatology. 1997;24:1645–1648
  56. Dohin-Caplanne S, Dugay J, Prophette B, et al. Atteinte hépatique et anémie hémolytique révélant une maladie de Still de l'adulte. La Revue de Médecine Interne. 1997;18:339–340
  57. Ota T, Higashi S, Suzuki H, et al. Increased serum ferritin levels in adult Still's disease. Lancet. 1987;1:562–563
  58. Gonzalez-Hernandez T, Martin-Mola E, Fernandez-Zamorano A, et al. Serum ferritin can be useful for diagnosis in adult onset Still's disease. Journal of Rheumatology. 1989;16:412–413
  59. Akritidis N, Giannakakis I, Giouglis T. Ferritin levels and response to treatment in patients with Adult Still's disease. Journal of Rheumatology. 1996;23:201–202
  60. Schiller D, Mittermayer H. Hyperferritinemia as a marker of Still's disease. Clinical Infectious Diseases. 1998;26:534–535
  61. Zandman-Goddard G, Shoenfeld Y. Ferritin in autoimmune diseases. Autoimmunity Reviews. 2007;6:457–463
  62. Lee MH, Means RT. Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance. American Journal of Medicine. 1995;98:566–571
  63. Van Reeth C, Le Moel G, Lasne Y, et al. Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease. Journal of Rheumatology. 1994;21:890–895
  64. Vignes S, Le Moel G, Fautrel B, et al. Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease. Annals of the Rheumatic Diseases. 2000;59:347–350
  65. Lambotte O, Costedoat-Chalumeau N, Amoura Z, et al. Drug-induced hemophagocytosis. American Journal of Medicine. 2002;112:592–593
  66. Lambotte O, Cacoub P, Costedoat N, et al. High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. Journal of Rheumatology. 2003;30:1027–1028
  67. Fardet L, Coppo P, Kettaneh A, et al. Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome. Arthritis and Rheumatism. 2008;58:1521–1527
  68. Zollner RC, Kern P, Steininger H, et al. Hyperferritinemia in Still syndrome in the adult and reactive hemophagocytic syndrome. Medizinische Klinik (Munich). 1997;92:494–498
  69. Arlet JB, Le TH, Marinho A, et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Annals of the Rheumatic Diseases. 2006;65:1596–1601
  70. Aellen P, Raccaud O, Waldburger M, et al. Maladie de Still de l'adulte avec coagulation intravasculaire disséminée (CIVD). Schweizerische Rundschau für Medizin Praxis. 1991;80:376–378
  71. Cabane J, Lebas J, Wattiaux MJ, et al. Pseudo-maladie de Still et néoplasie. 2 observations. La Revue de Médecine Interne. 1988;9:81–84
  72. Drenth JP, Haagsma CJ, van der Meer JW. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore). 1994;73:133–144
  73. Masson C, Simon V, Hoppe E, et al. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases. Joint Bone Spine. 2004;71:284–290
  74. Calabro JJ, Londino AV. Adult onset Still's disease. Journal of Rheumatology. 1986;13:827–828
  75. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still's disease. Journal of Rheumatology. 1992;19:424–430
  76. Fautrel B, Zing E, Golmard JL, et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore). 2002;81:194–200
  77. Masson C, Le Loet X, Liote F, et al. Comparative study of 6 types of criteria in adult Still's disease. Journal of Rheumatology. 1996;23:495–497
  78. Masson C, Le Loet X, Liote F, et al. Adult Still's disease. Part II. Management, outcome, and prognostic factors. Revue du Rhumatisme (English ed.). 1995;62:758–765
  79. Coffernils M, Soupart A, Pradier O, et al. Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome. Journal of Rheumatology. 1992;19:1425–1427
  80. Kraetsch HG, Rascu A, Kalden JR, et al. Clinical course and prognostic parameters in adult-onset Still's syndrome. Own experience and review of the literature. Medizinische Klinik (Munich). 1997;92:705–711
  81. Hirohata S, Kamoshita H, Taketani T, et al. Adult Still's disease complicated with adult respiratory distress. Archives of Internal Medicine. 1986;146:2409–2410
  82. Sampalis JS, Esdaile JM, Medsger TA, et al. A controlled study of the long-term prognosis of adult Still's disease. American Journal of Medicine. 1995;98:384–388
  83. Bisagni-Faure A, Job-Deslandre C, Menkes CJ. Intravenous methylprednisolone pulse therapy in Still's disease. Journal of Rheumatology. 1992;19:1487–1488
  84. Aydintug AO, D'Cruz D, Cervera R, et al. Low dose methotrexate treatment in adult Still's disease. Journal of Rheumatology. 1992;19:431–435
  85. Fautrel B, Borget C, Rozenberg S, et al. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. Journal of Rheumatology. 1999;26:373–378
  86. Church LD, Cook GP, McDermott MF. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nature Clinical Practice. Rheumatology. 2008;4:34–42
  87. Stankovic K, Grateau G. Auto inflammatory syndromes: Diagnosis and treatment. Joint Bone Spine. 2007;74:544–550
  88. Fitzgerald AA, Leclercq SA, Yan A, et al. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis and Rheumatism. 2005;52:1794–1803
  89. Lequerre T, Quartier P, Rosellini D, et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Annals of the Rheumatic Diseases. 2008;67:302–308
  90. Kraetsch HG, Antoni C, Kalden JR, et al. Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Annals of the Rheumatic Diseases. 2001;60:iii55–iii57
  91. Husni ME, Maier AL, Mease PJ, et al. Etanercept in the treatment of adult patients with Still's disease. Arthritis and Rheumatism. 2002;46:1171–1176
  92. Fautrel B, Sibilia J, Mariette X, et al. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Annals of the Rheumatic Diseases. 2005;64:262–266
  93. Iwamoto M, Nara H, Hirata D, et al. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthritis and Rheumatism. 2002;46:3388–3389
  94. Permal S, Wechsler B, Cabane J, et al. Treatment of Still disease in adults with intravenous immunoglobulins. La Revue de Médecine Interne. 1995;16:250–254
  95. Vignes S, Wechsler B, Amoura Z, et al. Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. Clinical and Experimental Rheumatology. 1998;16:295–298
  96. Marchesoni A, Ceravolo GP, Battafarano N, et al. Cyclosporin A in the treatment of adult onset Still's disease. Journal of Rheumatology. 1997;24:1582–1587
  97. Shojania K, Chalmers A, Rangno K. Cyclosporin A in the treatment of adult Still's disease. Journal of Rheumatology. 1995;22:1391–1392
  98. Ahmadi-Simab K, Lamprecht P, Jankowiak C, et al. Successful treatment of refractory adult onset Still's disease with rituximab. Annals of the Rheumatic Diseases. 2006;65:1117–1118

PII: S1521-6942(08)00092-2

doi: 10.1016/j.berh.2008.08.006

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 5 , Pages 773-792 , October 2008

Article Tools

* Image Usage & Resolution